Collectively, CD36 promotes the ubiquitination of GPC4 to de-activate β-catenin/c-MYC signaling cascades and downstream glycolytic target genes, repressing the glycolysis and tumorigenesis in CRC cells (Fang et al., 2019). This evidence concerns the gene MYC and colorectal carcinoma.